헤파린 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 투여 경로별, 성분별, 가용성별, 치료법별, 치료 영역별, 농도별, 유형별, 용기별, 지역별 - 업계 예측(2026-2033년)

Global Heparin Market size was valued at USD 7.51 Billion in 2024 and is poised to grow from USD 7.71 Billion in 2025 to USD 9.46 Billion by 2033, growing at a CAGR of 2.6% during the forecast period (2026-2033).

The global heparin market is a crucial segment within the healthcare and pharmaceutical industries, focusing on anticoagulant medications derived from animal tissues. It is primarily fueled by rising cardiovascular disease cases, an increasing aging population, and a higher volume of surgical procedures, leading to greater demand for anticoagulants. Additionally, lifestyle-related health issues heighten the need for heparin products, supported by increasing hospitalization rates. Ongoing research and development efforts aimed at creating advanced heparin delivery systems also contribute positively to market growth. However, challenges such as regulatory scrutiny, intense market competition, and potential complications like heparin-induced thrombocytopenia may hinder growth. Despite these obstacles, the market shows promise through opportunities in biosimilars, innovative drug delivery systems, and growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heparin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heparin Market Segments Analysis

Global Heparin Market is segmented by Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Unfractionated Heparin, Low Molecular Weight Heparin (LMWH) and Ultra-Low Molecular Weight Heparin (ULMWH). Based on Mode of Administration, the market is segmented into Oral Administration and Parenteral Administration. Based on Source, the market is segmented into Bovine and Porcine. Based on Ingredient, the market is segmented into Sodium, Calcium and Others. Based on Availability, the market is segmented into Raw and Processed. Based on Treatment, the market is segmented into Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism and Others. Based on Therapeutics, the market is segmented into Cardiovascular, Respiratory, Oncology, Nephrology, CNS and Others. Based on Strength, the market is segmented into 10 -1000 Unit, 1000 -5000 Unit, 5000- 25000 Unit and Others. Based on Type, the market is segmented into Generics and Brands. Based on Container, the market is segmented into Bottles, Bags, Vials and Others. Based on Packaging, the market is segmented into Glass and Plastic. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy and Others. Based on Application, the market is segmented into Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests and Others. Based on End User, the market is segmented into Hospitals, Clinics, Homecare, Ambulatory Surgical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heparin Market

The global Heparin market is significantly driven by the prevalence of cardiovascular diseases, which are the primary causes of mortality and disability worldwide. Conditions such as heart attacks, atrial fibrillation, and strokes greatly elevate the risk of thromboembolic disorders, thereby amplifying the need for heparin and similar anticoagulants. Additionally, the increasing incidence of pulmonary embolism (PE) and deep vein thrombosis (DVT) further fuels the demand for heparin, as it is considered the standard of care for managing these conditions. This combination of health challenges ensures a sustained requirement for effective anticoagulant therapies, supporting market growth.

Restraints in the Global Heparin Market

The global heparin market faces significant restraints due to the potential side effects associated with heparin therapy, particularly the risk of bleeding, which can lead to apprehension among patients and caution among healthcare providers. Additionally, conditions such as heparin-induced thrombocytopenia (HIT) pose serious risks that can undermine confidence in treatment protocols. Furthermore, the requirement for meticulous monitoring of activated partial thromboplastin time (aPTT) when using unfractionated heparin complicates the treatment regimen, particularly in outpatient settings, leading to more complex management routines. These factors collectively contribute to the challenges faced by the heparin market.

Market Trends of the Global Heparin Market

The Global Heparin market is currently witnessing a strong trend towards the development and adoption of biosimilars. As patents for original heparin formulations expire, the emergence of cost-effective biosimilars presents a viable alternative, enabling healthcare providers to manage costs while ensuring patient care remains uncompromised. This shift is particularly pronounced in major regions such as Europe and North America, where stakeholders are increasingly prioritizing affordability in drug procurement. The growing emphasis on these biosimilars underscores a broader market shift towards more sustainable and equitable healthcare solutions, reflecting an evolving landscape defined by enhanced competition and innovation in therapeutic options.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Heparin Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Unfractionated Heparin
• Low Molecular Weight Heparin (LMWH)
• Ultra-Low Molecular Weight Heparin (ULMWH)

Global Heparin Market Size by Mode of Administration & CAGR (2026-2033)

• Market Overview
• Oral Administration
• Parenteral Administration

Global Heparin Market Size by Source & CAGR (2026-2033)

• Market Overview
• Bovine
• Porcine

Global Heparin Market Size by Ingredient & CAGR (2026-2033)

• Market Overview
• Sodium
• Calcium
• Others

Global Heparin Market Size by Availability & CAGR (2026-2033)

• Market Overview
• Raw
• Processed

Global Heparin Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Deep Vein Thrombosis
• Pulmonary Embolism
• Arterial Thromboembolism
• Others

Global Heparin Market Size by Therapeutics & CAGR (2026-2033)

• Market Overview
• Cardiovascular
• Respiratory
• Oncology
• Nephrology
• CNS
• Others

Global Heparin Market Size by Strength & CAGR (2026-2033)

• Market Overview
• 10 -1000 Unit
• 1000 -5000 Unit
• 5000- 25000 Unit
• Others

Global Heparin Market Size by Type & CAGR (2026-2033)

• Market Overview
• Generics
• Brands

Global Heparin Market Size by Container & CAGR (2026-2033)

• Market Overview
• Bottles
• Bags
• Vials
• Others

Global Heparin Market Size by Packaging & CAGR (2026-2033)

• Market Overview
• Glass
• Plastic

Global Heparin Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy and Drug Store
• Online Pharmacy
• Others

Global Heparin Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pre-Surgical Procedures
• Post-Surgical Procedures
• Kidney Dialysis
• Diagnostic Tests
• Others

Global Heparin Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinics
• Homecare
• Ambulatory Surgical Centres
• Others

Global Heparin Market Size & CAGR (2026-2033)

• North America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
  • US
  • Canada
• Europe (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Mode of Administration, Source, Ingredient, Availability, Treatment, Therapeutics, Strength, Type, Container, Packaging, Distribution Channel, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Opocrin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioiberica S.A.U. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LEO Pharma A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aspen Holdings (South Africa)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gland Pharma (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Techdow USA (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biological E. Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Faran Shimi Pharmaceutical Company (Iran)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kamada Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations